Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 13, 2009

Enzo Biochem has appointed Kevin Krenitsky as president of its Enzo Clinical Labs subsidiary.

Prior to joining Enzo Clinical Labs, Krenitsky was CEO of Bioserve Biotechnologies. Previous to Bioserve, he was CEO of Parkway Clinical Laboratories. He also served as senior vice president and division head at SeraCare Life Sciences' Genomics Collaborative Division.

Patricia Bravo, General Manager of Chile-based research products distributor Segal, will become Sigma-Aldrich's sales and marketing manager for Chile following the acquisition of Segal by the St. Louis-based firm.

Shaun Lonergan has become CEO of Nerites, which develops new wound adhesives, and has joined the company's board of directors. Most recently, he was vice president of sales, marketing, and business development for Ibis Biosciences, which was sold to Abbott Molecular in January. Prior to that, he held "similar executive positions" at 454 Life Sciences and NimbleGen Systems. Earlier, he was vice president of corporate development at Third Wave Technologies.

Oligo manufacturer Girindus has named Steven Broadbent as its vice president of quality. According to the company, Broadbent previously held various positions at Archimica, Syntex, Roche, and Clariant.

W. Steven Burke is leaving his post as senior vice president for corporate affairs for the North Carolina Biotechnology Center to be come president of the Biofuels Center of North Carolina. Burke also has served since 2000 as vice chair of the Biotechnology Institute, a national nonprofit organization that promotes biotechnology education.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more